Nitric Acid

Nitric Acid is almost exclusively administered by a healthcare professional in a clinical setting. There is no standard 'daily dose' as its use is typically procedural.

• For Warts (Verrucae): A healthcare provider will apply a small amount of concentrated Nitric Acid (usually 70%) directly to the lesion using a glass rod or a precision applicator. This is often repeated at intervals of 1 to 2 weeks until the lesion is resolved.
• In Allergenic Testing: The concentration used is highly diluted and is governed by the specific protocol of the diagnostic test being performed. Dosing is measured in 'Protein Nitrogen Units' (PNU) or weight/volume ratios rather than milligrams of acid.

Nitric Acid must be used with extreme caution in pediatric populations due to the thinner nature of children's skin, which increases the risk of deep burns and scarring.

• Children (Ages 12 and older): Dosage is similar to adults but requires more precise application to avoid surrounding healthy tissue.
• Children (Under 12): Use is generally discouraged unless other treatments (such as cryotherapy or salicylic acid) have failed. Only a specialist should perform the application.

Renal Impairment

Since systemic absorption is minimal during topical use, dosage adjustments for renal impairment are generally not required. However, in cases of systemic nitrate toxicity, renal function must be monitored as the kidneys are the primary route of nitrate excretion.

Hepatic Impairment

No specific dosage adjustments are documented for patients with liver disease when Nitric Acid is used topically or as a diagnostic reagent.

Elderly Patients

Elderly patients often have thinner, more fragile skin. Healthcare providers should use smaller amounts and monitor the application site closely for signs of excessive tissue destruction or delayed healing.

Nitric Acid is NOT for oral consumption. It is a hazardous substance if swallowed.

• Topical Application: The area surrounding the lesion is often protected with a layer of petroleum jelly to prevent the acid from burning healthy skin. The acid is applied only to the target tissue, which will turn white and then yellow.
• Storage: In a clinical setting, Nitric Acid must be stored in a cool, dry place, away from organic materials and metals, in a glass-stoppered bottle. It is highly reactive.
• Administration Environment: Must be used in a well-ventilated area to avoid inhalation of nitrogen oxide fumes, which can be irritating to the respiratory tract.

Since Nitric Acid is used for procedural cauterization, a 'missed dose' simply means a delay in treatment. If you miss an appointment for a wart treatment, contact your doctor to reschedule. Missing a treatment may allow the wart to regrow or persist longer.

An 'overdose' of Nitric Acid typically refers to accidental ingestion or excessive topical application.

• Topical Overdose: Results in deep chemical burns, ulceration, and potential scarring. Immediate irrigation with copious amounts of water or a weak bicarbonate solution is required.
• Oral Ingestion (Emergency): This is a life-threatening medical emergency. Symptoms include severe pain in the mouth and throat, vomiting (often bloody), and shock. Do NOT induce vomiting. Seek emergency medical attention immediately.
• Inhalation Overdose: Exposure to fumes can cause pulmonary edema (fluid in the lungs). Move the person to fresh air and seek immediate help.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to apply this substance without medical guidance.

When Nitric Acid is used for its intended purpose of cauterization, certain 'side effects' are actually part of the therapeutic process. These include:

• Localized Pain: A sharp, stinging, or burning sensation at the site of application. This usually lasts for several minutes to an hour.
• Skin Discoloration: The treated area will almost certainly turn a bright yellow color (the xanthoproteic reaction). This is permanent for that specific piece of tissue until it sloughs off.
• Eschar Formation: The development of a hard, dry crust over the treated area. This is expected and should not be picked or removed prematurely.

• Erythema (Redness): Significant redness of the healthy skin surrounding the treatment site, often due to accidental contact or 'spreading' of the acid.
• Edema (Swelling): Mild to moderate swelling around the cauterized area.
• Pruritus (Itching): As the area begins to heal and the dead tissue separates, itching is common.

• Secondary Infection: If the cauterized area is not kept clean, bacteria may infect the site, leading to pus, increased pain, and fever.
• Hypertrophic Scarring: In some individuals, the healing process may result in a raised or thickened scar (keloid).
• Hypopigmentation: The new skin that grows under the sloughed eschar may be lighter than the surrounding skin, and this change can sometimes be permanent.

> Warning: Stop taking Nitric Acid and call your doctor immediately if you experience any of these.

1. 1Deep Tissue Ulceration: If the acid penetrates too deeply, it can cause a non-healing ulcer that may require surgical intervention.
2. 2Systemic Nitrate Toxicity: Though rare from topical use, symptoms include cyanosis (bluish skin), shortness of breath, and rapid heart rate (methemoglobinemia).
3. 3Severe Allergic Reaction (Anaphylaxis): While Nitric Acid is used in allergenic extracts, a patient may be allergic to the acid or the components of the extract itself. Symptoms include hives, swelling of the face or throat, and difficulty breathing.
4. 4Ocular Exposure: Accidental splashing into the eyes can cause permanent blindness and severe corneal burns. This requires immediate irrigation and emergency care.

Long-term or repeated exposure to Nitric Acid (particularly in occupational settings) can lead to chronic respiratory issues if fumes are inhaled. Topically, repeated cauterization of the same area can lead to chronic skin irritation and permanent changes in skin texture. There is no evidence that Nitric Acid is carcinogenic (cancer-causing) in humans when used as a localized medical treatment.

No FDA black box warnings currently exist for Nitric Acid when used as a component of allergenic extracts or as a topical cauterant. However, it is classified as a hazardous substance by OSHA and other safety organizations, requiring strict handling protocols to prevent severe chemical burns and respiratory damage.

Report any unusual symptoms or excessive pain to your healthcare provider immediately. Monitoring the healing site is essential to prevent complications like infection or scarring.

Nitric Acid is a highly reactive and corrosive substance. It must be handled with extreme care by trained medical professionals. It is not intended for self-administration. The primary risks associated with Nitric Acid are localized tissue destruction and, in rare cases of ingestion or inhalation, systemic toxicity.

No FDA black box warnings for Nitric Acid. However, users must adhere to the 'Danger' labels on clinical-grade Nitric Acid containers, which specify the risk of severe skin burns and eye damage.

• Allergic Reactions / Anaphylaxis Risk: When Nitric Acid is used as part of a Non-Standardized Food Allergenic Extract [EPC], there is a risk of inducing a severe allergic reaction. Patients undergoing allergy testing should be monitored for at least 30 minutes following administration.
• Chemical Burn Risk: Nitric Acid does not 'sting' immediately like other acids; there can be a slight delay before the burn is felt, which can lead to over-application. It must be neutralized or washed away if it contacts healthy skin.
• Respiratory Sensitivity: Patients with asthma or chronic obstructive pulmonary disease (COPD) may be more sensitive to the fumes of Nitric Acid. If used in a small room, ensure proper ventilation.
• Methemoglobinemia: There is a theoretical risk that absorbed nitrates could lead to methemoglobinemia, a condition where the blood cannot effectively carry oxygen. This is more common in infants than in adults.

For patients receiving frequent treatments or those undergoing extensive allergy testing, the following may be monitored:

• Skin Integrity: Regular inspection of the application site for signs of infection or excessive ulceration.
• Pulse Oximetry: If systemic absorption is suspected, to check for oxygen saturation levels.
• Follow-up Exams: To ensure the lesion (e.g., wart) is responding to treatment and not showing signs of malignancy (some skin cancers can mimic warts).

Topical application of Nitric Acid does not typically affect the ability to drive or operate machinery. However, if the procedure causes significant pain or if the patient receives a diagnostic injection that causes a systemic reaction (dizziness or lightheadedness), they should wait until symptoms resolve before driving.

There are no known direct interactions between topical Nitric Acid and alcohol consumption. However, alcohol can cause vasodilation (widening of blood vessels), which might theoretically increase the discomfort or inflammation at the site of a chemical burn.

Treatment with Nitric Acid can be stopped at any time without withdrawal symptoms. However, if a course of wart treatment is interrupted, the lesion may return. If an allergic reaction occurs during diagnostic testing, the procedure must be discontinued immediately and emergency protocols initiated.

> Important: Discuss all your medical conditions, especially skin sensitivities and respiratory issues, with your healthcare provider before starting Nitric Acid treatments.

Nitric Acid should never be mixed with the following substances, as it can cause explosive reactions or highly toxic fumes:

• Organic Solvents (e.g., Alcohol, Acetone): Mixing Nitric Acid with these can lead to a violent exothermic reaction.
• Metallic Powders: Can result in the release of flammable hydrogen gas or toxic nitrogen dioxide gas.
• Strong Bases (e.g., Sodium Hydroxide): Causes a violent neutralization reaction that can spray corrosive liquid.

• Other Caustics (e.g., Salicylic Acid, Podophyllin): If Nitric Acid is used in combination with other wart treatments, the risk of deep tissue damage and severe scarring is significantly increased. These treatments should generally not be applied to the same site simultaneously.
• Nitrate Medications (e.g., Nitroglycerin, Isosorbide): While topical absorption is low, there is a theoretical risk of additive vasodilatory effects if large amounts of Nitric Acid are absorbed systemically.

• Topical Corticosteroids: Using steroids on an area recently treated with Nitric Acid may delay the healing process and increase the risk of secondary infection by suppressing the localized immune response.
• Local Anesthetics: While sometimes used to manage the pain of cauterization, some anesthetics may react with the acid if not applied correctly, potentially reducing the efficacy of the cauterant.

There are no known food interactions with topically applied Nitric Acid. If used as part of a Non-Standardized Food Allergenic Extract [EPC], the interaction is the diagnostic goal (identifying the allergy), not a drug-food interference in the traditional sense.

• Vitamin C (Ascorbic Acid): When taken orally, Vitamin C can inhibit the conversion of nitrates to nitrites in the stomach. While not directly relevant to topical use, it may be relevant in cases of accidental ingestion.
• St. John's Wort: May increase skin sensitivity to light (photosensitivity), which could theoretically complicate the healing of a chemical burn.

• Urinary Nitrate Tests: Systemic absorption of Nitric Acid can lead to false-positive or elevated results in urinary nitrate/nitrite tests.
• Methemoglobin Levels: High systemic levels can interfere with pulse oximetry readings, showing a 'false' saturation of around 85% regardless of actual oxygen levels.

For each major interaction, the mechanism typically involves either a direct chemical reaction (incompatibility) or a pharmacodynamic overlap (additive tissue destruction or additive nitrate effects). Management involves separating treatments in time and space and ensuring the treatment area is clean and free of other chemicals.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially other skin treatments.

Nitric Acid must NEVER be used in the following circumstances:

• Malignant or Suspected Melanoma: Applying a caustic agent to a cancerous lesion can obscure the diagnosis and delay necessary surgical treatment. It may also provoke the spread of certain tumors.
• Facial Lesions: Due to the high risk of permanent scarring and the proximity to the eyes, Nitric Acid is generally contraindicated for use on the face.
• Mucous Membranes: Unless specifically directed by a specialist (e.g., for certain internal warts), it should not be applied to the inside of the mouth, nose, or anal canal due to the risk of severe mucosal erosion.
• Hypersensitivity: Known allergy to Nitric Acid or any component of the diagnostic extract.

Conditions requiring careful risk-benefit analysis include:

• Diabetes Mellitus: Patients with diabetes, particularly those with peripheral neuropathy or poor circulation, are at a much higher risk for non-healing ulcers and infections following chemical cauterization of the feet.
• Peripheral Vascular Disease (PVD): Similar to diabetes, poor blood flow to the extremities can prevent the skin from healing after the acid destroys the target tissue.
• Immunosuppression: Patients with HIV/AIDS or those on chemotherapy may have a diminished ability to heal and a higher risk of secondary infection at the treatment site.

Patients who have had severe reactions to other mineral acids (like Sulfuric Acid) or who have shown extreme sensitivity to nitrate-containing compounds should be treated with caution. While not a true 'allergy' in the protein-sense, chemical sensitivity can lead to exaggerated inflammatory responses.

> Important: Your healthcare provider will evaluate your complete medical history, including your circulation and ability to heal, before prescribing Nitric Acid.

Nitric Acid is classified as Pregnancy Category C (or equivalent). There are no adequate and well-controlled studies of Nitric Acid in pregnant women.

• Trimester-Specific Risks: During the first trimester, the focus is on avoiding any systemic stress or chemical exposure. While topical use is unlikely to reach the fetus, it should only be used if the potential benefit outweighs the risk.
• Teratogenicity: There is no evidence that localized topical application of Nitric Acid causes birth defects.

It is unknown whether Nitric Acid or its nitrate metabolites pass into breast milk in significant quantities following topical application. Because systemic absorption is minimal, it is generally considered compatible with breastfeeding, provided the acid is not applied to the breast or nipple area where the infant could ingest it directly.

Nitric Acid is not FDA-approved for self-use in children. In a clinical setting, it is used for children with recalcitrant warts, but only under the care of a dermatologist.

• Growth Effects: There are no known effects on bone growth or development.
• Special Dosing: Requires extreme precision. Children are more likely to move during the painful application, increasing the risk of accidental burns to healthy skin.

In patients over 65, the skin is often thinner (atrophic) and has a reduced blood supply.

• Healing Time: Expect a longer time for the eschar to fall off and for the skin to heal.
• Polypharmacy: Elderly patients are more likely to be on blood thinners (anticoagulants), which may complicate the healing of any deep chemical burn.

No dosage adjustment is typically required for topical use. However, if used as a Nitrogen Binding Agent in a systemic context (rare), the GFR (Glomerular Filtration Rate) must be monitored, as the kidneys are responsible for clearing nitrate ions.

Nitric Acid does not undergo significant hepatic metabolism. No adjustments are necessary for patients with Child-Pugh Class A, B, or C cirrhosis when the drug is used topically.

> Important: Special populations require individualized medical assessment to ensure that the caustic nature of the treatment does not lead to long-term complications.

Nitric Acid acts as a non-specific protein denaturant. Its primary molecular target is the peptide bond and the side chains of aromatic amino acids. Upon contact with tissue, the acid provides a high concentration of hydrogen ions (H+) and nitrate ions (NO3-). The hydrogen ions lower the pH drastically, causing the protein structures to unfold. Simultaneously, the nitrating action of the acid on tyrosine residues creates xanthoproteic acid, which is responsible for the yellow color and the immediate death of the treated cells. As a Nitrogen Binding Agent [EPC], it participates in the chemical sequestration of ammonia and other nitrogenous bases, which is a secondary pharmacological application in specialized metabolic reagents.

• Dose-Response: The depth of tissue destruction is directly proportional to the concentration of the acid and the duration of contact.
• Onset of Action: Immediate. Protein coagulation begins within seconds of contact.
• Duration of Effect: The chemical destruction is permanent for the affected cells. Healing of the site typically takes 2 to 4 weeks.
• Tolerance: There is no known pharmacological tolerance to the caustic effects of Nitric Acid; however, some warts may develop a thick keratin layer that makes them 'resistant' to penetration.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (Topical) |

| Protein Binding | 100% (at site of contact) |

| Half-life | 5-8 hours (Systemic Nitrate) |

| Tmax | N/A (Local effect is immediate) |

| Metabolism | Non-enzymatic dissociation |

| Excretion | Renal (as Nitrates) |

• Molecular Formula: HNO3
• Molecular Weight: 63.01 g/mol
• Solubility: Completely miscible in water; reacts with many organic solvents.
• Structure: A planar molecule with a central nitrogen atom bonded to three oxygen atoms, one of which is protonated.

Nitric Acid belongs to the class of Mineral Acids and is therapeutically categorized as a Caustic/Escharotic. Within the FDA's EPC system, it is uniquely cross-referenced as an Allergenic Extract component and a Nitrogen Binding Agent.